Phenobarbital (Benzobarbital) is a drug, white or off-white crystal powder, easily soluble in chloroform, ethanol and ether, slightly soluble in water.
The synthetic route of phenobarbital mainly involves the following steps:
1. Synthesis of methyl phenylacetate: benzoic acid and formic acid are condensed and dehydrated to produce methyl phenylacetate.
2. Synthesis of phenylacetyl chloride: methyl phenylacetate reacts with thionyl chloride to generate phenylacetyl chloride.
3. Synthesis of phenobarbital precursor-5-phenyl-5-isovaleric acid (5-Phenyl-5-isopropylbarbituric acid): phenylacetyl chloride reacts with isovaleryl urea to generate 5-phenyl-5 - Isovaleric acid.
4. Synthesis of phenobarbital: react 5-phenyl-5-isovaleric acid and ethanolamine under alkaline conditions to generate phenobarbital.
The complete synthetic route of phenobarbital is as follows:
Benzoic acid + formic acid → methyl phenylacetate
Methyl phenylacetate + thionyl chloride → phenylacetyl chloride
Phenylacetyl chloride + isovaleryl urea → 5-phenyl-5-isovaleric acid
5-Phenyl-5-isovaleric acid + ethanolamine → phenobarbital
It should be noted that this is only a basic route for the synthesis of phenobarbital, and the actual synthesis process may vary slightly due to different preparation requirements. When conducting laboratory operations, safety should be paid attention to, and reasonable operation and equipment selection should be carried out according to the actual situation.
Benzobarbital laboratory synthesis method steps are as follows:
1. Synthesis of methyl phenylacetate:
Under magnetic stirring, mix benzoic acid and formic acid and slowly add sulfuric acid catalyst (1 mL). Heated to 80°C and reacted for 4 hours. After cooling, add 10% sodium hydroxide solution to adjust the pH to 8-9. The product was extracted 3 times with ether to obtain methyl phenylacetate.
2. Synthesis of phenylacetyl chloride:
In a drop test tube, mix methyl phenylacetate and thionyl chloride, and add a small amount of catalyst (concentrated sulfuric acid). After stirring for 1 hour, the precipitate was removed by filtration to obtain phenylacetyl chloride.
3. Synthesis of 5-phenyl-5-isovaleric acid:
In a drop test tube, mix phenylacetyl chloride and isovaleryl urea, and add sodium carbonate catalyst. Heated to reflux and stirred for 2 hours to obtain 5-phenyl-5-isovaleric acid.
4. Synthesis of phenobarbital:
Mix 5-phenyl-5-isovaleric acid and ethanolamine, add a small amount of sodium hydroxide solution to the reflux device, and heat to reflux for 1 hour. After cooling, acid was added to adjust the pH to acidic, the product was extracted three times with chloroform, and the product was collected by distillation to obtain phenobarbital crystals.
It is important to note that phenobarbital is a narcotic drug and should only be administered in a trained laboratory. Safety needs to be paid attention to during the experiment, and the operation should be strictly followed the experiment process and safety operation rules.
Phenobarbital (Benzobarbital) is a barbiturate that was first synthesized in 1902 by French chemist Eugene Schloesing.
With the synthesis of phenobarbital, people began to study its pharmacological effects, and found that it has hypnotic, anxiolytic and antiepileptic effects. Therefore, phenobarbital was soon used in the clinical medical field and became a commonly used sedative, hypnotic and antiepileptic drug.
In the early 20th century, the use of phenobarbital was quite common, but as its side effects were better understood, its use was gradually limited. In the 1950s, the use of phenobarbital gradually decreased with the introduction of benzodiazepines (phenobarbital analogs).
Although phenobarbital's use is limited, it still plays a role in medical research, such as as an inducer in animal experiments. In addition, the study of phenobarbital will also help us better understand the pharmacological effects of sedatives and hypnotics, and promote the research and development of related drugs.
Although phenobarbital was widely used in the past, its use is relatively rare today. This is because phenobarbital has serious side effects such as dependence, drug resistance, overdose may cause respiratory failure, etc., and there are safer and more effective alternative drugs available.
Therefore, from the perspective of clinical application, the prospect of phenobarbital is not optimistic. However, from the perspective of drug research and development, phenobarbital still has certain potential. Phenobarbital can be used as a reference for the study of other barbiturates to help better understand the pharmacology of these drugs. In addition, the structure of phenobarbital can be used to develop new drug molecules to improve the adverse effects and disadvantages of barbiturates.
Generally speaking, although the clinical application prospect of phenobarbital is not optimistic, it still has certain potential in drug research and development.